Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from Allergic Rhinitis with symptoms aggravated in presence of pollutants: analysis of individual symptom scores

Anne K. Ellis; Margarita Murrieta-Aguttes; Sandy Furey; Christopher Carlsten

doi:10.1016/j.waojou.2020.100266

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from Allergic Rhinitis with symptoms aggravated in presence of pollutants: analysis of individual symptom scores

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100266 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100266

Author(s):

Anne K. Ellis ◽

Margarita Murrieta-Aguttes ◽

Sandy Furey ◽

Christopher Carlsten

Keyword(s):

Allergic Rhinitis ◽

Randomized Study ◽

Efficacy And Safety ◽

Single Center ◽

Phase 3 ◽

Double Blind ◽

Parallel Group ◽

Symptom Scores

Download Full-text

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from seasonal Allergic Rhinitis with symptoms aggravated in presence of pollutants

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100267 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100267

Author(s):

Anne K. Ellis ◽

Margarita Murrieta-Aguttes ◽

Sandy Furey ◽

Christopher Carlsten

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Randomized Study ◽

Efficacy And Safety ◽

Single Center ◽

Phase 3 ◽

Double Blind ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Advances in Therapy ◽

10.1007/s12325-020-01603-8 ◽

2021 ◽

Vol 38 (4) ◽

pp. 1889-1903

Author(s):

Yuqin Song ◽

Hui Zhou ◽

Huilai Zhang ◽

Wei Liu ◽

Yuerong Shuang ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Large B Cell Lymphoma ◽

Parallel Group ◽

Large B Cell

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.741267002.793590492 ◽

2021 ◽

Author(s):

Pedro Legua Leiva

Keyword(s):

Randomised Controlled Trial ◽

Controlled Trial ◽

Trichuris Trichiura ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

School Aged Children ◽

Pemba Island ◽

Parallel Group ◽

Randomised Controlled

Download Full-text

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30426-0 ◽

2019 ◽

Vol 7 (3) ◽

pp. 249-259 ◽

Cited By ~ 43

Author(s):

Florian von Groote-Bidlingmaier ◽

Ramonde Patientia ◽

Epifanio Sanchez ◽

Vincent Balanag ◽

Eduardo Ticona ◽

...

Keyword(s):

Multidrug Resistant ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Background Regimen ◽

Parallel Group

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Cited By ~ 17

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD

10.1183/1393003.congress-2017.pa1812 ◽

2017 ◽

Author(s):

Gary Ferguson ◽

Krishna K. Pudi ◽

Gregory Feldmann ◽

Srikanth Pendyala ◽

Chris N. Barnes ◽

...

Keyword(s):

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Muscarinic Antagonist ◽

Double Blind Placebo ◽

Parallel Group ◽

Long Acting ◽

Severe Copd

Download Full-text

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkn250 ◽

2008 ◽

Vol 62 (suppl_1) ◽

pp. i17-i28 ◽

Cited By ~ 92

Author(s):

I. Florescu ◽

M. Beuran ◽

R. Dimov ◽

A. Razbadauskas ◽

M. Bochan ◽

...

Keyword(s):

Staphylococcus Aureus ◽

Methicillin Resistant Staphylococcus Aureus ◽

Randomized Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Methicillin Resistant ◽

Vancomycin Resistant Enterococci ◽

Serious Infections ◽

Vancomycin Resistant

Download Full-text

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study

Sleep Medicine ◽

10.1016/j.sleep.2013.07.007 ◽

2013 ◽

Vol 14 (11) ◽

pp. 1085-1091 ◽

Cited By ~ 13

Author(s):

Yuichi Inoue ◽

Tetsuo Shimizu ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Jun Ishigooka ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Restless Legs ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study

Clinical & Experimental Allergy ◽

10.1111/j.1365-2222.2009.03257.x ◽

2009 ◽

Vol 39 (9) ◽

pp. 1338-1347 ◽

Cited By ~ 61

Author(s):

P. Kuna ◽

C. Bachert ◽

Z. Nowacki ◽

P. van Cauwenberge ◽

I. Agache ◽

...

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Symptomatic Treatment ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Download Full-text